Stockholders' Equity - Warrant activity (Details) - Warrant - USD ($) $ / shares in Units, $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Number of Units and Awards, Unvested Beginning Balance | 15,841 | |
| Warrants, Exercise | (890) | |
| Number of Units and Awards, Unvested Ending Balance | 14,951 | |
| Weighted Average Exercise Price, Outstanding | $ 0.6315 | |
| Weighted Average Exercise Price, Exercised | 0.0001 | |
| Weighted Average Exercise Price, Outstanding | $ 0.6691 | |
| Aggregate Intrinsic Value | $ 11 | $ 84 |
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options that exercised during the reporting period. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which equity instruments holders acquired shares when converting their equity instruments into shares. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the equity-based plan. No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Details
|